AHCO AdaptHealth Corp.
Services-Home Health Care Services · Nasdaq · SEC CIK 1725255 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.3%
TTM net income YoY-594.6%
TTM EPS YoY-632.1%
Revenue 3-yr CAGR0.3%
Net income 3-yr CAGR—
Margins
Gross margin15.9%
Operating margin-11.5%
Net margin-12.9%
FCF margin2.6%
EBITDA margin2.2%
Returns
ROE-28.6%
ROA-9.5%
ROIC (approx.)-8.9%
Asset turnover0.73x
Leverage & solvency
Liabilities / assets70.6%
Debt / equity1.54x
Current ratio1.13x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-1.42x
Accruals ratio-23.0%
Payout ratio—
Capex / revenue15.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $745.65M | $740.31M | $819.80M | $846.29M | $672.37M | $657.10M | $777.88M | $856.64M |
| Cost of revenue | $630.84M | $636.10M | $708.30M | $674.13M | $533.85M | $521.31M | $657.44M | $543.35M |
| Gross profit | $114.81M | $104.21M | $111.50M | $172.16M | $138.52M | $135.79M | $120.44M | $313.30M |
| SG&A expense | $88.66M | $96.09M | $95.91M | $107.89M | $88.14M | $95.26M | $86.85M | $204.61M |
| Operating income | -$155.92M | -$137.80M | $5.49M | -$73.28M | $43.37M | $65.69M | $23.17M | $97.67M |
| Interest expense | — | — | — | — | — | — | — | $27.76M |
| Pretax income | -$184.52M | -$165.33M | -$20.11M | -$97.99M | $17.99M | $38.16M | -$5.23M | $70.71M |
| Income tax | -$17.49M | -$21.23M | -$5.23M | $3.54M | $6.52M | $32.78M | $850,000 | $19.31M |
| Net income | -$153.99M | -$133.93M | -$16.04M | -$102.77M | $24.51M | $14.67M | -$7.21M | $50.26M |
| EBITDA | -$41.02M | -$25.00M | $111.96M | $24.23M | $133.47M | $150.49M | $117.52M | $188.20M |
| EPS (basic) | -1.13 | -0.99 | -0.12 | — | 0.17 | 0.10 | -0.05 | — |
| EPS (diluted) | -1.13 | -0.99 | -0.12 | — | 0.17 | 0.10 | -0.05 | — |
| Weighted avg. shares (diluted) | 136.40M | 136.12M | 135.78M | — | 137.21M | 137.07M | 134.80M | — |
| Balance sheet | ||||||||
| Cash & equivalents | — | — | $47.96M | $106.14M | $80.36M | $68.63M | $53.65M | $109.75M |
| Receivables | $395.87M | $390.39M | $391.97M | $370.90M | $380.32M | $393.59M | $418.45M | $408.02M |
| Inventory | $111.90M | $105.48M | $159.27M | $114.89M | $149.09M | $148.85M | $129.29M | $139.84M |
| Current assets | $839.09M | $797.48M | $687.48M | $728.90M | $724.82M | $658.00M | $745.17M | $755.79M |
| PP&E, net | $646.89M | $656.37M | $622.18M | $503.19M | $488.42M | $487.99M | $481.62M | $474.56M |
| Goodwill | $2.16B | $2.37B | $2.57B | $2.46B | $2.65B | $2.65B | $2.64B | $2.68B |
| Intangibles | $29.90M | $31.78M | $80.23M | $35.77M | $90.09M | $95.17M | $100.29M | $105.55M |
| Total assets | $4.20B | $4.34B | $4.42B | $4.32B | $4.38B | $4.35B | $4.44B | $4.49B |
| Current liabilities | $744.82M | $709.21M | $743.29M | $712.39M | $670.70M | $622.09M | $576.73M | $566.99M |
| Short-term debt | $16.25M | $8.12M | $24.38M | $20.31M | $16.25M | $16.25M | $16.25M | $16.25M |
| Long-term debt | $1.87B | $1.88B | $1.80B | $1.72B | $1.74B | $1.79B | $1.94B | $1.96B |
| Total debt | $1.88B | $1.89B | $1.82B | $1.74B | $1.76B | $1.81B | $1.96B | $1.98B |
| Total liabilities | $2.97B | $2.95B | $2.91B | $2.79B | $2.76B | $2.76B | $2.86B | $2.91B |
| Shareholders' equity | $1.23B | $1.38B | $1.51B | $1.52B | $1.62B | $1.59B | $1.57B | $1.57B |
| Net debt | — | — | $1.78B | $1.63B | $1.68B | $1.74B | $1.90B | $1.87B |
| Shares outstanding | 136.46M | 136.31M | 136.01M | 135.45M | 135.42M | 135.22M | 134.94M | 134.60M |
| Cash flow statement | ||||||||
| Operating cash flow | $156.59M | $145.30M | $93.72M | $183.18M | $161.07M | $161.99M | $95.53M | $150.41M |
| Capital expenditure | $105.53M | $166.24M | $121.21M | $103.90M | $94.24M | $88.67M | $95.58M | $77.34M |
| Free cash flow | $51.06M | -$20.94M | -$27.49M | $79.29M | $66.82M | $73.33M | -$58,000 | $73.08M |
| Investing cash flow | -$107.53M | -$202.71M | -$204.46M | -$124.47M | -$92.74M | $9.60M | -$95.58M | -$86.87M |
| Financing cash flow | -$11.67M | $52.74M | $52.56M | -$32.94M | -$56.60M | -$156.62M | -$56.04M | -$53.98M |
| Depreciation & amortization | $114.90M | $112.80M | $106.47M | $97.51M | $90.10M | $84.80M | $94.34M | $90.54M |
| Stock-based compensation | $1.00M | $5.40M | $6.53M | $5.14M | $5.20M | $6.00M | $5.30M | $4.27M |
| Share buybacks | — | — | — | — | — | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 35 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.